Telesta - Seeking Alpha article excerptI don't get tired of reading this. "Bioniche (Telesta) could be the most undervalued stock currently trading on the market, and I think certainly the most undervalued biotech stock.... There is a critical medical need for Bioniche's technology in a $1 billion market virtually free of real competition, which opens the door for massive revenue growth, while the sound financials limits downside risk. Overall, today's $0.20 share price appears to me as an excellent entry point for a genuine 10-bagger opportunity. One thing's for sure; opportunities of this magnitude are very rare."